Healthcare Insurance, Payer, Finance & Infrastructure Marketing, AI & Growth Consulting
Healthcare financing is where a clinical decision becomes an eligibility check, authorization, claim, remittance, denial, appeal, patient bill and eventually cash—if the transaction survives the trip.
I help health plans, payer organizations, benefits companies, TPAs, healthcare-finance businesses, revenue-cycle companies, clearinghouses, payment and eligibility platforms, value-based-care organizations and other healthcare infrastructure companies explain complicated systems clearly enough for members, providers, employers, partners and enterprise buyers to trust them and act.
Insurance is not the thing most people want. They want access to care, financial predictability and fewer surprises. The infrastructure earns its place when it makes those three things work better.
The healthcare system has a second circulatory system. It moves eligibility, authorizations, claims, data and money instead of blood.
When that system works, patients receive care, providers get paid, employers can manage benefits and health plans can control cost without making every interaction feel adversarial.
When it fails, the consequences become very human very quickly: delayed surgery, an unexpected bill, hours on hold, a clinic writing off revenue, a patient abandoning medication, an employer facing renewal shock or a hospital carrying receivables that should already be cash.
This is why I do not treat payer and healthcare-finance marketing as ordinary B2B lead generation. The company has to explain complex financial machinery while proving that the machinery produces a better healthcare result, better administrative result or both.
Coverage, claims, risk, reimbursement and the infrastructure underneath care.
There are easier ways to lose a customer than sending a twelve-page explanation of benefits nobody can explain.
A healthcare-finance company can have excellent technology and weak adoption because the provider workflow is miserable. A health plan can have competitive benefits and poor retention because members cannot understand the network. An RCM company can advertise a better collection rate while creating more work for the practice. A payer can shorten authorization turnaround and still frustrate providers because requirements are impossible to find.
I want the operational truth before the campaign. Who pays? Who bears risk? Who uses the product? Who controls access? Which data must move? What gets denied? What happens when a member changes plans? What is regulated? Where does revenue actually come from, and where does it leak?
“The payer” can be an insurer, employer, government program, managed-care plan or risk-bearing provider organization.
Commercial insurers
Individual and group carriers price coverage, build networks, adjudicate claims, manage utilization and compete on premiums, benefits, service and provider access.
Medicare
Traditional Medicare pays under federal benefit and payment rules, while Medicare Advantage places coverage and significant financial risk inside private health plans contracted with CMS.
Medicaid & CHIP
Federal-state programs combine public financing with state administration and, in many states, managed-care organizations that contract to manage benefits and networks.
Self-funded employers
The employer can bear claims risk while hiring an insurer or TPA for administration, networks, utilization management and other services.
Provider-sponsored risk
ACOs, delegated arrangements, provider-sponsored plans and other models can put physicians or health systems closer to responsibility for total cost and quality.
Pharmacy benefit
PBMs, Part D sponsors, specialty pharmacy networks, rebates, formularies and utilization tools create a separate but deeply connected medication-finance infrastructure.
Administrative vendors
Clearinghouses, eligibility systems, payment networks, RCM, claims editing, payment integrity and data platforms make the financing system function behind the scenes.
Consumers
Premiums, deductibles, copays, coinsurance, out-of-network exposure and uncovered services make patients direct financial participants even when another payer is involved.
A health plan is simultaneously a financial product, care-access system, network and customer-service business.
Individual market
Individual plans compete on premium, deductible, network, formulary, benefits, subsidy context and member experience. Plan marketing must accurately describe coverage rather than simplify away the parts consumers most need to understand.
Small and large group
Employer-sponsored products add brokers, benefits consultants, HR teams and renewal economics to the buying system. The member uses the plan, but the employer often chooses it.
HMOs, PPOs, EPOs and other designs
Network rules, referrals, out-of-network benefits and cost-sharing influence access and perceived value. Acronyms only become useful when the member understands what changes.
Network differentiation
A low premium can lose its appeal if the member's doctors, hospital or drugs are not covered. Provider directory accuracy therefore becomes a marketing and operations issue.
Service operations
Call centers, portals, appeals, ID cards, claims status and benefit explanations shape the brand after enrollment. The member's most memorable interaction may happen when something is denied.
Medical loss ratio
The ACA generally requires insurers to spend at least 80% of premium revenue in individual/small-group markets and 85% in large-group markets on clinical care and quality improvement, with rebates when applicable standards are not met.
Current CMS reference: Medical Loss Ratio.
Medicare Advantage is where insurance operations, government payment, risk adjustment, networks and consumer marketing all meet.
Bid, benchmark & payment
MA plans operate under CMS payment methodology, county benchmarks and risk adjustment rather than ordinary commercial premium economics alone.
Risk adjustment
Accurate diagnosis and encounter data affect risk-adjusted payment. Coding strategy must remain clinically and legally defensible; growth does not justify diagnoses unsupported by the record.
Stars & quality
Quality, member experience, medication measures and other performance dimensions influence plan operations and economics. Marketing teams should understand the operational drivers instead of treating Stars as a badge.
Supplemental benefits
Dental, vision, hearing and other benefits can support differentiation, but members need to understand network, limits and practical usability.
Special Needs Plans
D-SNPs, C-SNPs and I-SNPs serve populations with particular eligibility or care needs. Product positioning should reflect the population rather than merely another plan variant.
Utilization management
CMS has progressively tightened MA utilization-management rules, including continuity requirements and limits on how prior authorization and internal coverage criteria may be used.
References: CMS 2026 MA enrollment outlook, 2026 Rate Announcement and MA/Part D MLR.
Traditional Medicare is not an insurance company, but it is one of the largest payment systems healthcare businesses have to understand.
Part A
Hospital, skilled nursing, hospice and other covered institutional services operate under federal benefit and payment systems rather than commercial network contracts.
Part B
Physician, outpatient, diagnostic, DME and other services rely on fee schedules, coverage policy, coding and claims administration.
Part D
Prescription drug coverage is administered through private plans under Medicare rules and increasingly influenced by negotiated drug pricing, benefit redesign and pharmacy-benefit infrastructure.
MACs
Medicare Administrative Contractors process claims and perform other functions in defined jurisdictions. Provider finance teams need to distinguish CMS policy from contractor operations.
Coverage
National Coverage Determinations, Local Coverage Determinations and statutory benefit rules can influence whether services are reimbursable.
Appeals
Medicare includes structured appeals processes. Revenue-cycle strategy should distinguish coverage disputes from coding, documentation and administrative defects.
There is no single “Medicaid market.” There are fifty states, territories, eligibility systems and contracting environments layered onto federal law.
Fee-for-service Medicaid
States can pay providers directly under state-plan and waiver authorities, with payment levels and administrative processes varying substantially.
Managed care
States frequently contract with managed-care organizations to administer benefits, networks, utilization management and other functions for enrolled populations.
CHIP
The Children's Health Insurance Program works alongside Medicaid to cover eligible children under state and federal program structures.
Eligibility churn
Coverage transitions can affect continuity, network access, prescriptions and provider revenue. Enrollment communication is therefore not simply administrative.
Provider economics
Payment rates, supplemental payment structures, managed-care contracts, uncompensated-care realities and service mix affect whether providers can sustainably participate.
State-specific strategy
A national payer or vendor needs architecture that can scale while acknowledging state policy, procurement, benefits and local delivery systems.
CMS publishes continuously updated Medicaid and CHIP enrollment and operations snapshots.
Open enrollment compresses a complicated financial and healthcare decision into a few weeks of comparison.
CMS reports that 23.1 million consumers selected or were automatically re-enrolled in 2026 coverage through HealthCare.gov and state-based Exchanges.
Premium and subsidy
The consumer sees a premium after applicable advance premium tax credits, but total value also depends on deductible, cost-sharing, network and prescriptions.
Metal levels
Bronze, Silver, Gold and other plan categories describe actuarial-value structures rather than quality. Marketing should avoid suggesting the metal name alone determines which plan is best.
Plan comparison
Consumers may need to check doctors, hospitals, drugs, expected use and total financial exposure. A low premium can be expensive when the needed care sits outside the network.
Agents and brokers
Licensed agents can be important acquisition and education channels. CMS maintains specific Marketplace registration and compliance resources for brokers.
Retention
Automatic renewal is not the same as informed plan choice. Member communication can encourage active review when networks, premiums or benefits change.
Fraud and consent
Enrollment systems require appropriate consumer authorization. CMS has increased enforcement around unauthorized or improper enrollments.
Current source: CMS 2026 Exchange Open Enrollment Report.
The company buying the benefit and the employee using it are two different customers.
Fully insured
An insurer generally bears the claims risk in exchange for premium under the policy while the employer contributes according to its benefit strategy.
Self-funded
The employer generally bears the financial risk for covered claims and can hire administrators, networks and vendors to operate the benefit.
ASO arrangements
An insurer can provide administrative services only—claims administration, networks, care management or other functions—without assuming the employer's underlying claims risk.
Benefit consultants
Brokers and consultants influence plan design, carrier selection, renewal, stop-loss, vendor strategy and employee communication.
Employee experience
The employer may choose the plan, but employees judge it through access, bills, prescriptions, support and the provider network.
Benefit strategy
Employers balance recruitment, retention, affordability and total compensation with a cost line capable of moving materially every year.
The U.S. Department of Labor's 2026 self-insured-plan report notes that self-funded plan sponsors generally bear health-benefit claims risk and may purchase stop-loss coverage against large losses. DOL Self-Insured Health Benefit Plans 2026.
Self-funding does not mean the employer starts adjudicating medical claims in the conference room.
Third-party administrators
TPAs can administer eligibility, claims, networks, customer service, reporting and other functions for employer plans or other payers.
Stop-loss
Specific and aggregate stop-loss can protect a self-funded employer from unusually large individual or total claims exposure depending on policy terms.
Reinsurance
Risk-transfer structures can stabilize insurer or risk-bearing organization exposure beyond ordinary expected claims.
Vendor orchestration
Employers may combine medical networks, PBMs, navigation, behavioral health, telehealth and other vendors. Integration determines whether the employee sees a benefit ecosystem or six login screens.
Reporting
Self-funded buyers want cost, utilization, trend and outcome visibility. Reports should answer business questions rather than demonstrate how many fields exist in the warehouse.
Fiduciary context
Employer health plans can involve ERISA fiduciary duties and other legal obligations. Strategy should recognize the issue without pretending marketing consultants provide benefit-plan legal advice.
Medication financing has its own parallel universe of formularies, tiers, rebates, specialty networks and prior authorization.
Formulary management
Plans and PBMs organize covered drugs into formularies and tiers, influencing member cost-sharing and prescribing pathways.
Rebates and contracting
Manufacturer, PBM and plan economics can involve negotiated rebates, fees and other contractual arrangements. Public marketing should avoid pretending a headline list price equals the net cost to every party.
Specialty pharmacy
High-cost therapies may involve specialty-pharmacy networks, limited distribution, prior authorization, benefit investigation and patient-support programs.
Medical versus pharmacy benefit
Infused and clinician-administered drugs may be financed differently from retail prescriptions, creating different authorization, billing and site-of-care pathways.
Utilization management
Prior authorization, step therapy and quantity limits can affect access. The commercial opportunity is to make benefit requirements easier to understand and execute, not merely harder to bypass.
2026 regulatory frontier
CMS proposed new federal requirements in April 2026 to extend modern electronic prior-authorization standards to drugs for affected payers. It remains a proposed rule unless and until finalized.
Drug commercialization and manufacturer strategy are treated separately in my Pharmaceutical Marketing work.
Current regulatory reference: CMS-0062-P — 2026 proposed drug prior-authorization rule.
A provider network is a promise that care will actually be there when the member tries to use the card.
Contracting
Hospitals, physicians, labs, ancillary providers and plans negotiate rates, terms, products, utilization requirements and administrative obligations.
Network adequacy
Access depends on specialty, geography, appointment availability and whether listed providers actually participate. Directory accuracy matters to both compliance and consumer trust.
Credentialing
Provider credentialing and contracting can delay participation and payment. The process should be distinguished from payer enrollment and clinical privileging, which are related but not identical.
Rate structures
Fee schedules, case rates, DRGs, per diems, percent-of-charge terms, capitation and value-based incentives create very different economics.
Provider relations
Plans compete for provider cooperation as well as members. A network that is difficult to work with can create friction long before a contract terminates.
Contract analytics
Organizations need to understand effective reimbursement by service line, payer and contract—not merely the nominal rate buried in a fee schedule.
Provider-side implications connect directly with my Hospital & Health System and Physician & Medical Practice work.
Prior authorization is supposed to manage appropriate use. It should not become a scavenger hunt.
CMS's 2024 Interoperability and Prior Authorization final rule is now partly in live operational effect.
2026 decision timelines
For affected payers, CMS requires prior-authorization decisions for covered non-drug items and services within 72 hours for expedited requests and seven calendar days for standard requests, subject to the rule's scope and program-specific requirements.
Specific denial reasons
Affected payers must provide a specific reason when denying covered prior-authorization requests, improving the information providers need to respond or appeal.
Public metrics
Beginning in 2026, affected payers must publicly report certain aggregated prior-authorization metrics annually, including information from the previous year.
Clinical criteria
Utilization-management criteria should be findable, current and connected to the actual service. Hidden criteria create provider burden and brand distrust.
Workflow integration
The best authorization technology sits inside ordering and clinical workflows so requirements can be identified before the patient is scheduled around an assumption.
Drugs remain separate
The 2024 CMS rule's core prior-authorization provisions focused on items and services other than drugs; CMS proposed a separate drug-prior-authorization rule in 2026.
References: CMS-0057-F fact sheet and CMS Prior Authorization API FAQs, updated 2026.
The member should not have to start their medical history over because they changed insurance cards.
Patient Access API
CMS's interoperability framework requires affected payers to make specified claims, encounter and other data available to members through standards-based APIs. New requirements add prior-authorization data.
Provider Access API
Affected payers must support an API allowing in-network providers with a treatment relationship to access specified claims, encounter, USCDI and prior-authorization data subject to the rule's requirements.
Payer-to-Payer API
Plan changes should not erase useful history. The new API framework is designed to facilitate specified data exchange between payers at member request.
Prior Authorization API
FHIR-based prior authorization is intended to allow providers to identify requirements, submit requests and receive payer decisions more electronically.
2027 implementation
Many of the major API requirements under CMS-0057-F have compliance dates beginning January 1, 2027, even though several operational prior-authorization provisions began in 2026.
Data governance
Interoperability increases utility and also increases the need for identity, consent, privacy, security, provenance and reliable data mapping.
Current CMS implementation resources: CMS Interoperability & Prior Authorization Final Rule.
The claim is not a PDF invoice. It is a standardized electronic conversation among organizations that rarely use the same software.
CMS's HIPAA Administrative Simplification standards require covered entities to use adopted transaction standards for applicable electronic exchanges. The details are technical, but the business implications are simple: rejected claims, mapping errors, missing eligibility and remittance problems become delayed cash and staff work.
Reference: CMS Adopted Standards & Operating Rules.
Healthcare spent decades perfecting electronic claims and then faxed the medical record that explained the claim.
CMS changed that architecture in March 2026 by finalizing the first HIPAA-adopted standards for electronic healthcare claims attachments.
X12 275 / 277
The final rule adopts X12 Version 6020 standards for additional information supporting a claim and for health-plan requests for additional claims information.
HL7 clinical attachments
The rule adopts specified HL7 C-CDA and attachments implementation guides to support clinical documentation such as records, notes, imaging and lab results.
Electronic signatures
The rule includes electronic-signature requirements intended to authenticate claims-attachment transactions securely.
Claims only
CMS did not finalize prior-authorization attachment standards in this rule because of alignment concerns with other prior-authorization standards work.
Implementation timing
The final rule became effective May 26, 2026. Compliance deadlines are 24 months from the effective date.
Business opportunity
Attachment automation can reduce faxing, manual indexing and missing-document cycles for providers, plans, clearinghouses and technology vendors.
CMS projects roughly $781 million in annual industry savings from the finalized claims-attachment standards. CMS-0053-F Fact Sheet, March 20, 2026.
The most important company in the payment chain may be the one the patient never knows exists.
Format normalization
Healthcare clearinghouses can convert nonstandard information into standard transactions or vice versa, helping providers and payers exchange data.
Claim scrubbing
Edits can identify format, coding or payer-specific defects before submission. The business value is fewer preventable rejections and denials.
Connectivity
One clearinghouse connection can reduce the number of direct technical interfaces a provider organization needs to maintain with individual payers.
Remittance normalization
835 data can be mapped back to patient accounting systems so cash posting and denial workflows can become more automated.
Eligibility
Real-time eligibility transactions help front desks and revenue-cycle teams understand active coverage and benefits before services are delivered.
Covered-entity status
Healthcare clearinghouses are HIPAA covered entities, which creates privacy, security and administrative-simplification responsibilities beyond ordinary SaaS connectivity.
CMS explains clearinghouse and covered-entity roles in its current Administrative Simplification overview.
The revenue cycle starts before the patient arrives and can remain unfinished months after the appointment ends.
Registration
Identity, demographics, coverage and plan information have to be accurate before the first claim ever exists.
Eligibility & benefits
Coverage verification can identify active plan status, cost-sharing and benefit requirements before treatment or scheduling.
Authorization
Services requiring prior authorization need approval before the encounter under applicable payer rules to reduce access delays and preventable denials.
Charge capture
Services have to become complete, accurate billable charges connected to documentation and the right codes.
Coding & CDI
Clinical documentation integrity and coding affect claims, quality, risk, reporting and reimbursement. Automation should assist defensible accuracy, not manufacture complexity.
Claim submission
Clean electronic claims require correct payer, identifiers, coding, modifiers and transaction formatting.
Denials & follow-up
Teams investigate nonpayment, correct preventable errors, appeal appropriate denials and track root causes rather than treating every account as unique chaos.
Patient balance
After insurer adjudication, the patient may owe deductibles, copays, coinsurance or noncovered amounts. Communication now becomes part of the revenue cycle.
A denial is a financial event. A pattern of denials is an operating signal.
Front-end denials
Eligibility, authorization, coverage and registration problems often begin before the claim is created. Fixing upstream workflow is more valuable than becoming faster at appeals.
Coding & documentation
Missing documentation, coding mismatch or medical-necessity support can trigger denials. Clinical and revenue teams need a shared root-cause vocabulary.
Contractual underpayment
A paid claim can still be wrong. Contract-management systems compare allowed reimbursement with expected terms and identify underpayments.
Appeals
Appeals need evidence, deadlines, payer-specific process and the ability to distinguish a defensible disagreement from a claim that should simply be corrected.
Payment integrity
Payers use prepayment and postpayment controls to identify duplicate, erroneous, unsupported or potentially fraudulent payment. Poorly designed edits can also create provider abrasion.
Fraud, waste & abuse
Claims analytics and investigation can protect program and plan funds. Marketing should be careful not to describe every high-cost or anomalous claim as fraud before investigation supports that conclusion.
The clinical experience can be excellent and the financial experience can still make the patient regret choosing the organization.
Estimates
Patients increasingly expect useful estimates before scheduled care. An estimate should explain assumptions rather than imply a guaranteed final bill when payer adjudication may change it.
Financial counseling
Complex procedures may require help understanding coverage, authorization, deductible, coinsurance, payment plans and assistance options.
Statements
A patient bill should explain what was charged, what insurance allowed, what the plan paid and why the remaining balance belongs to the patient.
Payment plans
Flexible payment arrangements can improve affordability and collections when terms, fees and consumer protections are clear.
Financial assistance
Hospitals and other organizations may maintain financial-assistance policies under applicable requirements. The patient should be able to find and understand them.
Collections
Healthcare debt involves illness, insurance complexity and financial vulnerability. Revenue strategy should respect consumer-protection requirements and the reputational consequences of aggressive collection practices.
Healthcare prices have become data products whether the industry likes it or not.
CMS's 2026 hospital price-transparency changes make hospital machine-readable files more specific about real allowed amounts and organizational accountability.
Machine-readable files
Hospitals must publish standard-charge information in the CMS-required machine-readable format, including payer-specific negotiated information where applicable.
2026 allowed amounts
Effective January 1, 2026, CMS replaced the estimated allowed amount field with median, 10th percentile and 90th percentile allowed amounts plus the count of allowed amounts under specified circumstances.
Remittance data
CMS requires hospitals to use EDI 835 remittance or an equivalent source over a specified historical lookback when calculating these allowed-amount data elements.
NPIs
Hospitals must encode relevant Type 2 NPIs in their machine-readable files under the 2026 requirements.
Executive attestation
The 2026 rules add a stronger attestation framework and identification of the hospital senior official responsible for complete and accurate data.
Commercial use
Transparency data can support contracting analytics, consumer tools, competitive intelligence and pricing products—but usefulness depends on normalization and context.
Current reference: CMS Hospital Price Transparency — CY 2026 Policy Changes.
A patient should not become the collection mechanism for a contract dispute they never knew existed.
Consumer protections
The No Surprises Act limits out-of-network cost sharing and balance billing in specified emergency, facility-based nonemergency and air-ambulance situations.
Plan/provider dispute
For qualifying disputes where another state or federal payment method does not control, plans and nonparticipating providers may use the Federal independent dispute resolution process.
Operational volume
The IDR system has processed far more disputes than initially expected. The 2026 final rule says more than 5.1 million disputes had been submitted by January 31, 2026.
2026 IDR final rule
Federal agencies finalized additional requirements around payment/denial information, remittance codes, registration, dispute initiation, eligibility review, batching and fee processes.
Provider communication
Revenue-cycle and contracting teams need to distinguish protected surprise-billing claims from ordinary out-of-network claims and state-specific rules.
Patient communication
Consumer-facing explanations should focus on rights and next steps rather than requiring the patient to understand qualifying payment amounts or arbitration mechanics.
Reference: Federal IDR Operations Final Rule, 2026.
Fee-for-service asks what was done. Value-based care increasingly asks what happened to the patient and the total cost.
Shared savings
ACOs can earn a portion of savings when quality and spending performance meet program requirements. More advanced tracks also expose organizations to shared losses.
Capitation
Per-member payment can shift financial responsibility toward the organization managing the population, creating incentives around prevention, utilization and care coordination.
Bundled payments
Episode-based models create a defined payment and accountability window around a procedure or condition rather than paying each component independently.
Quality measurement
Value contracts depend on specific quality measures, attribution and data. “Better outcomes” is not enough when the contract defines what better means numerically.
Risk coding
Patient acuity influences expected cost and risk adjustment in multiple models. Accurate documentation matters; upcoding is not a growth strategy.
Care redesign
The economic model works only if operations change: primary care access, transitions, specialist coordination, medication management and high-risk patient outreach.
Current CMS source: 2026 Medicare ACO Participation Highlights.
In a risk-bearing healthcare business, growth can increase revenue and increase the probability of losing money at the same time.
Premium revenue
Plans receive premium or government payment before knowing exactly which members will need expensive care. Pricing and risk adjustment exist because healthcare utilization is uneven.
Medical cost
Claims cost, trend, specialty drugs, hospital utilization and high-cost cases can move financial performance dramatically.
Medical loss ratio
MLR links premium revenue to clinical and quality spending under statutory program rules. It is not simply gross margin with a healthcare name.
Risk adjustment
Risk models compensate for expected differences in population acuity. Accurate data and documentation are operational necessities.
Reinsurance / stop-loss
Risk transfer can limit exposure to catastrophic or aggregate claims while creating additional pricing and contract decisions.
Administrative cost
Claims operations, service, sales, brokers, technology and compliance all sit outside direct medical claims. Better automation can matter materially at scale.
Drug financing becomes especially complicated where manufacturer pricing, covered entities, contract pharmacies, Medicare and Medicaid rules intersect.
340B purpose
The 340B Drug Pricing Program requires participating manufacturers to provide discounted prices on covered outpatient drugs to eligible safety-net covered entities under federal law.
Covered entities
Eligible hospitals, health centers and other organizations participate under program-specific eligibility and compliance requirements.
Duplicate discounts
Federal policy prohibits manufacturers from being required to provide both a 340B discount and a Medicaid drug rebate for the same drug unit.
Claims data
340B administration increasingly depends on claims-level identifiers, contract-pharmacy data, accumulators and reconciliation systems.
2026 pilot development
HRSA announced a revised voluntary 340B Rebate Model Pilot in July 2026 for a limited set of drugs, with selected arrangements planned for January 2027. It is a specific pilot, not a replacement of the entire program.
Safety-net economics
340B strategy affects pharmacy operations, hospital finance, manufacturers and community access. Marketing content should not substitute for program-specific legal and compliance analysis.
Current source: HRSA Revised 340B Rebate Model Pilot, July 31, 2026.
Healthcare payment technology has to connect a clinical event to money without pretending healthcare is ordinary ecommerce.
Patient payments
Cards, ACH, digital wallets, payment plans and online portals can reduce friction when balances, receipts and account matching remain accurate.
Provider payments
Payers can use EFT and remittance workflows to move funds and explain adjudication. Enrollment, banking changes and fraud controls need strong operational governance.
Premium payments
Employer, member and marketplace premium flows create another financial transaction layer distinct from claims reimbursement.
Financing products
Patient financing can expand affordability for high-cost care, but credit terms, disclosures and consumer-protection obligations belong with appropriate financial and legal expertise.
Reconciliation
Payments need to match claims, remittances, patient accounts and general ledgers. Automation that moves money without clean reconciliation simply creates faster accounting problems.
Embedded finance
Healthcare platforms increasingly place eligibility, estimation, payment and financing inside scheduling and patient workflows rather than treating finance as a separate back office.
Healthcare finance is an obvious AI market because it contains enormous volumes of repetitive work and equally enormous consequences when automation is wrong.
Eligibility automation
Systems can check coverage and benefit data before visits and identify likely missing information. The output still needs to reflect payer-specific limitations and timing.
Authorization automation
AI can identify requirements, extract documentation and assemble requests. Clinical approval criteria and final decisions remain governed by payer policy and applicable regulation.
Coding support
AI can assist coding and documentation review. Human oversight matters because a fluent code suggestion is not automatically supported by the record.
Denial prediction
Models can identify claims likely to deny and surface patterns by payer, service or rule. The higher-value use is preventing the defect upstream.
Payment integrity
Analytics can detect duplicate, anomalous or potentially improper claims. Governance is needed to avoid converting statistical unusualness into automatic accusation.
Member service
Conversational systems can explain benefits and claims status when grounded in authoritative plan data and designed to escalate appropriately.
Contract analytics
AI can extract and compare reimbursement terms, amendments and fee schedules, but financial interpretation still needs knowledge of the actual contract and claim behavior.
Forecasting
Claims trend, utilization and member data can support forecasts. Healthcare risk is not static, and models should not be sold as certainty machines.
Human accountability
When automation affects access, coverage or payment, the organization needs clear ownership for errors, appeals, exceptions and model performance.
Health-plan marketing has to sell a product most customers hope not to need very much.
Open enrollment
Consumers compare premium, network, prescriptions and cost-sharing under deadline pressure. The strongest communication helps people understand tradeoffs rather than hiding them behind benefit-count headlines.
Welcome and onboarding
ID cards, portals, PCP selection, pharmacy, telehealth and benefits should be understandable before the member becomes sick.
Benefit utilization
A plan can offer useful benefits that members never discover or understand. Education can improve value without encouraging unnecessary care.
Network communication
Provider-network changes create disruption. Members need timely, accurate information about what changes and what alternatives exist.
Appeals and grievances
The brand is tested most when the member disagrees with a decision. Clear rights, deadlines and next steps reduce some of the frustration even when the answer remains no.
Retention
Renewal is affected by premium and benefits, but service, access and accumulated trust can influence whether members actively shop away.
Healthcare infrastructure companies often know exactly which 300 organizations could buy from them.
That is an account-based marketing problem much more than a broad-reach advertising problem.
Health-plan buyers
Claims, prior-auth, payment, analytics and member-experience vendors may sell to operations, technology, clinical, finance, compliance and procurement stakeholders inside the same plan.
Provider buyers
RCM and finance vendors may need CFO, revenue-cycle, IT, compliance and clinical alignment before purchase.
Employer buyers
Self-funded solutions may sell through benefits executives, consultants, brokers, TPAs or direct enterprise relationships.
Procurement
Security, BAAs, implementation, data rights, service levels, pricing and integration can determine whether an attractive product ever gets through diligence.
Sales enablement
ROI models, implementation guides, security documentation, buyer-specific case studies and technical proof often move enterprise deals more than another general brand campaign.
Expansion
One line of business, state, hospital, product or business unit can become the entry point for broader enterprise adoption when value is measured clearly.
Healthcare finance search ranges from “is my doctor in network?” to “X12 275 claims attachment implementation.”
Consumer intent
Members search coverage, networks, deductibles, prior authorization, appeals, bills and plan comparisons. The content should reduce uncertainty without providing individualized insurance advice.
Provider intent
Practices search payer rules, claim status, authorization, coding, reimbursement and RCM questions. Operational documentation can be high-value acquisition content.
Employer intent
Benefits leaders search self-funding, stop-loss, plan administration, vendor alternatives and cost-management strategies.
Technical intent
EDI, FHIR, X12, APIs, attachments and interoperability documentation can attract engineers and enterprise buyers who would never search a generic marketing phrase.
AI answer visibility
Entity relationships should make plan type, buyer, member population, transaction, regulatory role and integration model obvious to generative systems.
Trust
Healthcare finance content should distinguish law, regulation, proposed rules, current operational policy and company-specific interpretation rather than blending them into one confident paragraph.
The best KPI depends on which side of the claim you are standing on.
| Business | Useful measures | What can mislead |
|---|---|---|
| Health plan | Enrollment, retention, MLR, claims trend, quality, call resolution, grievances, network access and member satisfaction. | Enrollment growth without risk, utilization and retention context. |
| TPA / ASO | Lives administered, claims accuracy, turnaround, service levels, client retention and cost per member. | Transaction volume without quality and client economics. |
| RCM vendor | Clean claim rate, denial rate, days in AR, net collection, underpayments, cost to collect and implementation time. | Gross collections without payer mix and baseline context. |
| Clearinghouse | Transaction acceptance, connectivity, uptime, payer reach, turnaround and exception rates. | Total transactions without successful downstream completion. |
| Value-based organization | Benchmark performance, total cost, quality, utilization, attribution, risk adjustment and shared savings/losses. | One utilization metric detached from financial methodology. |
| Patient-finance platform | Estimate accuracy, digital adoption, payment conversion, bad debt, cost to collect and patient satisfaction. | Payment conversion without affordability and consumer experience. |
Healthcare finance is national policy filtered through local contracts, networks and state regulation.
Florida
Florida combines large Medicare, Medicaid, commercial, Marketplace and self-funded populations with major health systems and a large older population. Plan and provider economics can vary sharply by county and market.
State regulation
Insurance regulation, Medicaid programs, network requirements, surprise-billing rules and licensure can change by state. National platforms need state-aware architecture.
Local provider markets
Negotiating leverage, hospital consolidation, specialist supply and employer concentration can make the same health-plan product economically different across metropolitan areas.
Geography is supporting context here. The main expertise is the healthcare financing system itself.
Show me the claim, contract, workflow or member journey before showing me the ad campaign.
Maybe the health plan has strong benefits and a member-experience problem. Maybe the RCM company has a good product and no authority with CFOs. Maybe the clearinghouse needs technical search visibility. Maybe the self-funded benefits company is explaining everything in consultant language and nothing in employer language. Maybe the provider is blaming denials while the real problem begins at registration.
I work across healthcare, technology, AI, data, search, content, enterprise sales and business strategy. That combination matters in payer and finance markets because the problem can move from actuarial logic to a call center to a FHIR endpoint to a hospital CFO in one conversation.
I am not an actuary, insurance broker, benefit-plan attorney, coding auditor, reimbursement attorney, licensed insurance producer or financial adviser. I do not interpret a specific policy or contract as professional legal or insurance advice. My role is to understand the commercial and operational system well enough to position, market and improve it intelligently.
Healthcare insurance, payer, finance & infrastructure FAQs
The simplest way into this market is usually to follow one clinical service all the way from coverage to cash.
What does a healthcare insurance and payer marketing consultant do?
I help health plans, payer organizations, benefits companies, TPAs, healthcare-finance firms, revenue-cycle companies, clearinghouses and healthcare infrastructure businesses connect positioning, member or enterprise growth, technical content, SEO, AI search, websites, sales enablement and measurement to the actual financing and operating model.
Is a payer the same thing as a health insurance company?
Not always. Commercial insurers are payers, but Medicare, Medicaid, CHIP, self-funded employers, managed-care organizations and risk-bearing provider entities can also finance or administer healthcare in different ways.
Can you help commercial health insurance companies?
Yes. Strategy can include plan positioning, member acquisition, broker and employer channels, open enrollment, network communication, digital experience, retention, content, SEO and enterprise growth.
Can you help Medicare Advantage plans?
Yes. Medicare Advantage strategy can include member communication, plan positioning, provider networks, supplemental-benefit communication, Stars-related member experience, digital discovery and marketing within applicable CMS rules.
How many people are expected to be in Medicare Advantage in 2026?
CMS reported that plan projections indicated about 34 million Medicare Advantage enrollees in 2026, representing roughly 48% of all people enrolled in Medicare, while also noting actual enrollment could be more robust than plan projections.
Can you help Medicaid managed-care plans?
Yes. Medicaid managed-care strategy can involve member communications, provider networks, state-specific positioning, access, digital experience and enterprise initiatives. Medicaid structures vary significantly by state.
Can you help ACA Marketplace health plans?
Yes. Marketplace strategy can include open-enrollment campaigns, plan comparison content, broker support, provider-network clarity, member onboarding, retention and local or state search visibility.
How large is the 2026 Marketplace?
CMS reports that 23.1 million consumers selected or were automatically re-enrolled in 2026 Marketplace coverage through HealthCare.gov and State-Based Exchanges.
Can you help self-funded employers and health-benefit companies?
Yes. I can help self-funded benefits companies, TPAs, navigation platforms and other vendors explain their value to employers, benefits consultants and employees while connecting product strategy to claims, networks, utilization, administration and member experience.
What is the difference between fully insured and self-funded health coverage?
In a fully insured arrangement the insurance carrier generally bears covered claims risk in exchange for premium. In a self-funded arrangement the employer generally bears claims risk while often hiring an insurer or TPA for administration and purchasing stop-loss coverage to limit specified risks.
What does a TPA do in healthcare?
A third-party administrator can perform functions such as claims administration, eligibility, customer service, network access, reporting and other plan operations for an employer or payer without necessarily bearing the underlying insurance risk.
What is stop-loss insurance?
Stop-loss insurance is coverage used by self-funded plans to protect against unusually large individual claims or aggregate claims exposure depending on the policy. It does not convert the underlying employer health plan into ordinary fully insured coverage.
Can you help PBMs?
Yes. PBM and drug-benefit strategy can include formulary communication, specialty-drug workflows, payer and employer positioning, member education, enterprise marketing, search and product strategy while leaving pharmacy-benefit legal and actuarial matters to qualified specialists.
What is prior authorization?
Prior authorization is a utilization-management process requiring a plan or payer to approve specified items, services or drugs before coverage or payment under applicable plan rules. Requirements vary by payer, service and program.
What changed for prior authorization in 2026?
Under CMS's 2024 Interoperability and Prior Authorization final rule, affected payers began complying with several operational requirements in 2026, including specified decision timeframes, denial-reason requirements and public reporting of certain prior-authorization metrics.
What are CMS's prior-authorization decision timeframes?
For impacted payers and covered non-drug items and services under CMS-0057-F, CMS requires decisions within 72 hours for expedited requests and seven calendar days for standard requests, subject to the rule's scope and program-specific requirements.
Does CMS's 2024 prior-authorization rule apply to prescription drugs?
The core prior-authorization requirements in CMS-0057-F focused on items and services other than drugs. In April 2026 CMS separately proposed CMS-0062-P to extend modern electronic prior-authorization requirements to drugs for affected payers. That drug rule is proposed, not final, as of this writing.
What is the Prior Authorization API?
CMS-0057-F requires affected payers to implement a FHIR-based Prior Authorization API that can allow providers to determine requirements, submit requests and receive decisions electronically. Major API compliance dates begin in 2027.
What is a Provider Access API?
Under CMS-0057-F, affected payers must implement a standards-based Provider Access API that can share specified claims, encounter, USCDI and prior-authorization data with in-network providers who have a treatment relationship with the patient, subject to the rule's requirements.
What is a Payer-to-Payer API?
The Payer-to-Payer API is designed to let members request that specified healthcare data move from one payer to another when coverage changes, helping preserve useful history across plan transitions.
Can you help payer interoperability companies?
Yes. I can help FHIR, API, prior-authorization, eligibility, claims and healthcare-data companies with positioning, technical content, enterprise GTM, SEO, AI search and sales enablement.
What are the main HIPAA administrative healthcare transactions?
Adopted standards include transactions for healthcare claims, eligibility and benefits, claim status, prior authorization and referrals, payment/remittance, coordination of benefits, enrollment and other administrative exchanges. Common X12 examples include 837 claims, 270/271 eligibility and 835 remittance.
What is an 837 claim?
The ASC X12N 837 is the HIPAA-adopted standard transaction used for institutional, professional and dental healthcare claims or equivalent encounter information.
What is an 835 remittance?
The ASC X12N 835 is used for healthcare claim payment and remittance information. It explains payer adjudication and payment information and can be paired with electronic funds transfer.
What is a healthcare clearinghouse?
Under HIPAA, a healthcare clearinghouse is an organization that processes nonstandard health information into a standard format or vice versa for another organization. Clearinghouses can connect providers and payers, validate claims and support transaction exchange.
What changed for electronic claims attachments in 2026?
CMS finalized the first HIPAA-adopted standards for electronic healthcare claims attachments in March 2026. The rule adopts specified X12 and HL7 standards plus electronic-signature requirements and has compliance deadlines 24 months after its May 26, 2026 effective date.
Can you help revenue-cycle management companies?
Yes. RCM strategy can include category positioning, CFO and practice targeting, SEO, technical content, denial and collection messaging, enterprise ABM, websites, case studies and sales enablement.
What is revenue cycle management?
Revenue cycle management is the financial and administrative process that connects patient registration, eligibility, authorization, charge capture, coding, claims, payment, denials, patient balances and collections.
Can you help coding, CDI and denial-management companies?
Yes. I can help companies explain coding, documentation integrity, denial prevention, appeals, underpayment recovery and payment-integrity technology while keeping claims appropriately supported by clinical documentation and payer rules.
What is payment integrity?
Payment integrity refers to processes used by payers to identify and prevent incorrect, duplicate, unsupported or potentially improper payments before or after claims are paid. It can include rules, analytics, audits and investigations.
Can you help patient-payment and healthcare-fintech companies?
Yes. Strategy can cover patient estimates, digital payments, financing, payment plans, provider payments, reconciliation and embedded financial workflows while leaving regulated lending and financial advice to qualified professionals.
What changed in hospital price transparency in 2026?
CMS's 2026 hospital price-transparency rules require additional data including median, 10th percentile and 90th percentile allowed amounts plus counts in specified circumstances, and added organizational NPI and senior-official attestation requirements.
What is the No Surprises Act?
The No Surprises Act created federal protections against many surprise out-of-network bills, including specified emergency services, certain nonemergency services at participating facilities and air-ambulance services, while establishing a federal independent dispute resolution process for qualifying payer-provider payment disputes.
What changed in the Federal IDR process in 2026?
A 2026 final rule added and revised requirements around plan payment and denial information, remittance codes, payer registration, open negotiation, dispute initiation, eligibility review, batching and fees for the Federal independent dispute resolution process.
What is value-based care?
Value-based care is a broad term for payment models that connect reimbursement or financial accountability to quality, outcomes, utilization or total cost rather than paying only for each individual service.
What is an ACO?
An Accountable Care Organization is a group of healthcare providers that coordinates care for a defined population under a payment model that can reward better quality and more efficient spending and, in some models, expose the organization to shared financial losses.
How large is the Medicare Shared Savings Program in 2026?
CMS reports 511 Shared Savings Program ACOs serving 12.6 million people with Traditional Medicare in performance year 2026. The most recently reconciled 2024 performance year generated $4.1 billion in shared savings and $2.5 billion in Medicare savings.
Can you help ACOs and value-based-care companies?
Yes. I can help ACOs, enablement companies, risk platforms and value-based-care organizations with positioning, provider acquisition, enterprise marketing, patient communication, technical content, AI search and growth strategy.
What is medical loss ratio?
Medical loss ratio measures the share of premium revenue spent on clinical services and qualifying quality-improvement activities under applicable rules. ACA standards are generally 80% in the individual and small-group markets and 85% in the large-group market; Medicare Advantage and Part D plans have an 85% minimum MLR requirement.
Can you help 340B-related healthcare organizations?
Yes, from the marketing, communication and business-strategy side. 340B involves covered entities, manufacturers, pharmacies, claims and safety-net finance, but program compliance and legal interpretation should remain with qualified 340B and legal specialists.
What is the 2026 340B rebate pilot?
In July 2026 HRSA announced a revised voluntary 340B Rebate Model Pilot for a limited set of covered outpatient drugs, with selected manufacturer rebate arrangements planned to begin January 1, 2027. It is a specific pilot rather than a wholesale replacement of 340B.
Can you help health plans use AI?
Yes. AI can support eligibility, authorization, claims, coding, payment integrity, member service, analytics and forecasting. Systems that affect access or payment should have strong validation, governance, human escalation and accountability.
Can you provide SEO for healthcare finance companies?
Yes. Search strategy can cover consumer benefits questions, payer workflows, claims standards, revenue-cycle topics, FHIR APIs, prior authorization, RCM, payment integrity and enterprise buyer intent while keeping regulatory explanations current.
Can you help healthcare finance companies appear in AI search?
Yes. GEO, AEO and AI Search Optimization can clarify the company's role, buyer, transaction, plan type, integrations, regulatory context and value proposition so generative systems can represent it more accurately.
Can you help payer and healthcare-finance companies with ABM?
Yes. Many payer and healthcare-infrastructure companies sell to a finite set of plans, health systems, employers, TPAs or provider groups. Account-based marketing can align content, media, sales activity and buying-group strategy around those accounts.
Do you only work with healthcare payers in Florida?
No. Paper Boat Media is based in DeLand, Florida, and Florida is a major Medicare, Medicaid, Marketplace and commercial insurance market, but payer and healthcare-finance work is national. Geography matters when state regulation, Medicaid policy, networks and provider markets change the business.
Are you an insurance broker, actuary or healthcare attorney?
No. I am a business, marketing, AI and growth strategist. I do not provide actuarial opinions, policy interpretation, legal advice, coding audit opinions or individualized insurance recommendations. I work alongside the appropriate specialists when a project requires them.
Can you work as a consultant, fractional CMO or hands-on marketing partner?
Yes. Engagements can range from focused positioning, content, search, ABM or website projects to retained advisory, fractional CMO leadership and hands-on execution across digital strategy, paid media, AI search and analytics.
What should I bring to an initial payer or healthcare-finance strategy conversation?
Bring the financing model, buyer, member or provider population, regulatory context, transaction flow, integrations, sales cycle, current metrics and the point where adoption, reimbursement, member experience or growth is getting stuck.
Tell me where coverage, payment, adoption or trust breaks down.
Maybe the health plan needs members to understand the product. Maybe the RCM company needs CFOs to understand the platform. Maybe the clearinghouse has extraordinary infrastructure and invisible search authority. Maybe a provider is collecting slowly because the problem starts before the claim is generated. Maybe the value-based-care company can model risk but cannot explain why a physician should join.
Bring me the workflow and the business model. I can work backward from there.